| Mrs Charity Cabrera Magcalas, CRNA | |
|
12222 Merit Dr Ste 600, Dallas, TX 75251-3294 | |
| (972) 715-5000 | |
| (972) 715-9976 |
| Full Name | Mrs Charity Cabrera Magcalas |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 12222 Merit Dr Ste 600, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003002205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3564 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jerry W. Lewis Md Pa | 8123301785 | 3 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Entity Name | Allied Anesthesia & Pain Management Consultants, L.l.p. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942327192 PECOS PAC ID: 3375506058 Enrollment ID: O20041104000828 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Entity Name | Sanjai Isaac Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134458003 PECOS PAC ID: 0143358853 Enrollment ID: O20100517000277 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Entity Name | Texas Pain Relief Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003246299 PECOS PAC ID: 2668603952 Enrollment ID: O20140331000940 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Entity Name | Jerry W. Lewis Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225589369 PECOS PAC ID: 8123301785 Enrollment ID: O20170207000367 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Charity Cabrera Magcalas, CRNA Po Box 840853, Dallas, TX 75284-0853 Ph: (972) 233-1999 | Mrs Charity Cabrera Magcalas, CRNA 12222 Merit Dr Ste 600, Dallas, TX 75251-3294 Ph: (972) 715-5000 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Escherichia coli (E. coli) are bacteria that live all around and inside of us. Most E. coli are harmless, but some strains can cause illness, and can even, in extreme cases, be deadly. With recent outbreaks of E. coli around the world, there is a fear of acquiring an infection from these bacteria.
The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Nearly two-thirds of the herbal medicines used by cancer patients in the Middle East have potential health risks, according to a new survey led by Assistant Professor Eran Ben-Arye, of the Technion-Israel Institute of Technology.
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
› Verified 5 days ago
Jennie A Potts, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 13601 Preston Rd, 1000w, Dallas, TX 75240 Phone: 972-715-5000 | |
Eric Lara, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 469-419-2850 | |
Ms. Justina Osagioduwa Nwokedi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976 | |
Lauren Carter Segerson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976 | |
Hannah Neipp Murdock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976 | |
Jeannie K Murphy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy, Suite 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976 |